GlassScriptPhysician profile
Jennifer Dust
NPI 1255537197
$1,567.83
in general payments reported to CMS, 2019-2025
17 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $232 · 2021: $206 · 2022: $159 · 2023: $210 · 2024: $212 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $294.88 | 2023-2025 | Gemtesa, Myfembree |
| Abbvie INC. | $285.42 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Merz North America, INC. | $205.68 | 2019 | |
| Sage Therapeutics, LLC | $142.55 | 2020-2025 | Zurzuvae |
| Amgen INC. | $108.88 | 2020-2024 | Prolia, Evenity |
| Urovant Sciences INC | $107.16 | 2021 | |
| Myovant Sciences INC. | $85.62 | 2021 | |
| Astellas Pharma US INC | $76.81 | 2024-2025 | Veozah |
| Laborie Medical Technologies Corp. | $62.95 | 2022-2023 | |
| Hologic Sales and Service, LLC | $48.77 | 2019-2025 | Aptima |
| Pfizer INC. | $35.71 | 2024-2025 | |
| Organon LLC | $34.49 | 2024-2025 | Nexplanon |
| Boston Scientific Corporation | $22.15 | 2025 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $16.20 | 2023 | |
| Channel Medsystems, INC. | $14.91 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $13.02 | 2019 | |
| Allergan, INC. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Dust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.